TORONTO, ON–(Mar 12, 2014) – Theralase Technologies Inc. (OTCBB: TLTFF) (TSX VENTURE: TLT) sells patented, superpulsed laser technology to healthcare practitioners to heal damaged tissue and eliminate pain. Theralase is also developing the next generation cancer treatment combining patented light activated compounds with laser technology to hunt down and destroy cancer.

Roger Dumoulin-White, President and CEO of Theralase will be interviewed live by host Michael Yorba on Clear Channel Business Talk Radio’s The Traders Network Show.

In today’s exclusive 2-segment interview, Mr. Dumoulin-White will discuss new developments in their therapeutic laser technology and how Theralase is breaking new ground researching and developing patented Photo Dynamic Compounds (PDCs) that have shown an ability to target and effectively destroy cancer when light activated by Theralase’s patented laser technology.

We encourage all interested investors and prospective customers across the US to tune in and listen live via Clear Channel’s nationally syndicated iHeart Radio stream.

The live interview details are as follows:

Live Stream via iHeart: http://www.iheart.com/live/4276/?autoplay=true
Date: Wednesday, March 12, 2014
Start Time: 1:05pm CDT | 11:05am PDT | 2:05pm EDT (U.S.)
Network: Clear Channel
Station: DFW 1190AM KFXR
Show: The Traders Network
Host: Michael Yorba

About Clear Channel: Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.

About Michael Yorba: Mr. Yorba is the founder of Yorba Media and featured host on Clear Channel. For the past six years he has produced and hosted The Traders Network Show broadcasted live daily on Clear Channel DFW 1190AM KFXR from 1pm – 3pm CST, Monday-Friday following the Glenn Beck Show.

Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on Clear Channel’s The Traders Network Show.

About Theralase Technologies Inc.: Theralase Technologies Inc. (OTCBB: TLTFF) (TSX VENTURE: TLT) designs, manufactures and markets patented, superpulsed laser technology utilized in effectively healing damaged tissue by eliminating pain, reducing inflammation and accelerating healing for a wide range of nerve, muscle and joint conditions, such as low back pain, knee pain and neck pain. Theralase is also researching and developing the next generation cancer treatment with patented Photo Dynamic Compounds (PDCs) that are able to target and effectively destroy cancer when light activated by Theralase’s patented laser technology.

For further information please visit www.theralase.com, regulatory filings may be viewed by visiting www.sedar.com.

This press release contains forward-looking statements, which reflect the Company’s current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation to update these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

A www.1800PublicRelations.com PR Event